Stanford gains access to Twist's 'library of libraries'

By The Science Advisory Board staff writers

Twist Bioscience has granted Stanford University access to its antibody discovery and optimization services and its "library of libraries" for biologics discovery.

Researchers from Stanford's Innovative Medicines Accelerator program will have access to the library, which consists of a range of preconstructed and validated synthetic antibody libraries and proprietary discovery and optimization capabilities of Twist Biopharma, a division of Twist Bioscience.

Twist and Stanford hope that the newly granted access to these resources will accelerate antibody discovery against a wide range of therapeutic targets.

Financial details of the deal were not disclosed.

Copyright © 2021

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking